Skip to main content
. 2016 Mar 8;86(10):920–930. doi: 10.1212/WNL.0000000000002441

Table 3.

Clinical and MRI outcomes in the core Teriflunomide Multiple Sclerosis Oral (TEMSO) and extension studies (modified intent-to-treat population)

graphic file with name NEUROLOGY2015657304TT3.jpg

graphic file with name NEUROLOGY2015657304TT3A.jpg